home / stock / axnx / axnx news

AXNX News and Press, Axonics Modulation Technologies Inc. From 12/12/19

Stock Information
Company Name: Axonics Modulation Technologies Inc.
Stock Symbol: AXNX
Market: NASDAQ
Website: axonics.com
Menu
AXNX AXNX Quote AXNX Short AXNX News AXNX Articles AXNX Message Board
Get AXNX Alerts

News, Short Squeeze, Breakout and More Instantly...
AXNX - Axonics® Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), (“Axonics”), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today...
AXNX - Axonics® Provides Survey Results from Physician Seminar Series Showcasing the Recently FDA Approved Axonics r-SNM® System

326 Physicians, Representing Nearly a Third of the Top 1,000 SNM Implanters in the U.S., Attended Axonics-Sponsored Seminars over the Past Two Months Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel imp...

AXNX - Health Canada Approves Full-Body MRI Labeling for the Axonics® Sacral Neuromodulation System

Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“r-SNM®”) devices for the treatment of bladder and bowel dysfunction, today announced Health Ca...

AXNX - Sanford Health Now Implanting Axonics® Sacral Neuromodulation Systems

Among Largest Rural Health Systems in the U.S. Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder an...
AXNX - Axonics® Announces Closing of $110 Million Public Offering of Common Stock

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), (“Axonics”), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today...

AXNX - Axonics® Announces Agreement to Supply its Sacral Neuromodulation System to The University of Tennessee Medical Center

Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today announced that it has enter...

AXNX - Axonics® Announces Pricing of Public Offering of Common Stock

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) (“Axonics”), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today ...
AXNX - Axonics launches $110M equity offering; shares down 3% after hours

Axonics Modulation Technologies (NASDAQ: AXNX ) slips  3%  after hours in reaction to its $110M public offering of common stock, $100M from the company and $10M from selling shareholders. More news on: Axonics Modulation Technologies, Inc., Healthcare stocks news, Stocks on the...

AXNX - Axonics® Announces Proposed Public Offering of Common Stock

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today announced that it has comm...

AXNX - Axonics Modulation Technlogs INC (AXNX) Q3 2019 Earnings Call Transcript

Image source: The Motley Fool. Axonics Modulation Technlogs INC   (NASDAQ: AXNX) Q3 2019 Earnings Call Nov 14, 2019 , 4:30 p.m. ET Operator Continue reading

Previous 10 Next 10